YOLFTbeta
Nutriband Inc

Nutriband Inc

NTRB · NASDAQ · Healthcare / Biotechnology

6.10USD+0.13 (+2.18%)

Price History

Full chart

Market Stats

Previous Close5.97
Open5.87
Day Range5.80 – 6.24
52-Week Range2.80 – 9.19
Volume28.93K
Market Cap100.04M
P/E (TTM)0.00
Forward P/E370.37
EPS-0.60
Dividend Yield0.00%
Beta2.04
50-Day Avg4.72
200-Day Avg4.14

About

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gareth Sheridan
  • Employees0
  • Headquarters121 South Orange Avenue, Orlando, FL, United States, 32801, USA
  • Websitehttps://www.nutriband.com

Leadership

  • Mr. Serguei MelnikFounder, President, Company Secretary & Executive Chairman · b. 1974
  • Mr. Gareth SheridanFounder, CEO & Director · b. 1990
  • Mr. Gerald GoodmanCFO & Chief Accounting Officer · b. 1948
  • Dr. Alan Smith Ph.D.COO & President of 4P Therapeutics · b. 1966
  • Dr. Jeffrey Patrick Pharm.D.Chief Scientific Officer · b. 1970
  • Mr. Michael MyerPresident of Pocono Pharmaceutical · b. 1984
  • Mr. Tyler OverkHead of Active Intelligence · b. 1984

Financials

Income Statement

Currency: USD2016-01-312017-01-312018-01-312019-01-312020-01-312021-01-312022-01-312023-01-312024-01-312025-01-312026-01-31
Total Revenue000245.28K370.65K943.70K1.42M2.08M2.09M2.14M2.04M
Growth (%)----+51.11%+154.61%+50.70%+46.23%+0.27%+2.62%-4.83%
Cost of Revenue000288.30K549.11K582.38K917.84K1.33M1.22M1.44M1.47M
Gross Profit000-43.02K-178.46K361.32K504.31K750.41K862.11K699.30K566.31K
Gross Margin----17.54%-48.15%38.29%35.46%36.08%41.34%32.68%27.81%
Operating Expense400151.26K171.95K3.29M1.79M2.96M4.43M4.90M5.73M7.39M8.88M
Operating Income-400-151.26K-171.95K-3.33M-1.97M-2.60M-3.93M-4.15M-4.87M-6.69M-8.32M
Operating Margin----1358.11%-531.35%-275.08%-276.33%-199.45%-233.63%-312.62%-408.41%
EBITDA-400-151.26K-2.67M-3.29M-2.56M-2.48M-5.74M-4.11M-5.12M-10.18M-8.01M
EBITDA Margin----1343.02%-689.71%-263.05%-403.57%-197.45%-245.61%-475.51%-393.45%
Net Income-400-151.26K-2.67M-3.33M-2.80M-3.21M-8.42M-4.81M-5.49M-10.48M-8.23M
Net Income Margin----1358.11%-754.10%-340.52%-592.23%-231.33%-263.04%-489.86%-404.08%
R&D0000-0411.38K982.23K1.96M3.12M1.89M
R&D as % of Total Revenue---0.00%-0.00%28.93%47.23%94.01%145.75%92.85%
Interest Expense000073.41K280.69K118.42K8.29K75.81K21.41K22.54K
Interest Expense % of Total Revenue---0.00%19.81%29.74%8.33%0.40%3.64%1.00%1.11%

Balance Sheet

Currency: USD2016-01-312017-01-312018-01-312019-01-312020-01-312021-01-312022-01-312023-01-312024-01-312025-01-312026-01-31
Total Assets33037.73K164.90K2.81M2.20M9.93M12.74M9.46M7.52M7.47M7.55M
Total Liabilities11.80K14.62K43.39K403.01K2.02M2.82M880.38K883.39K1.08M1.04M868.45K
Total Equity-11.47K23.11K121.51K2.40M175.43K7.11M11.86M8.57M6.44M6.43M6.68M
Cash10027.12K0474.65K10.18K151.99K4.89M1.99M492.94K4.31M4.57M
Total Debt10.60K10.47K31.05K40.00K321.62K1.79M134.57K185.81K241.28K186.35K245.49K
Net Debt10.50K-16.66K31.05K-434.65K311.44K1.64M-4.76M-1.80M-251.66K-4.13M-4.33M

Cash Flow

Currency: USD2016-01-312017-01-312018-01-312019-01-312020-01-312021-01-312022-01-312023-01-312024-01-312025-01-312026-01-31
Operating Cash Flow-147.92K-147.92K-92.86K-1.11M-894.47K-297.06K-2.81M-2.99M-3.53M-4.63M-5.13M
Investing Cash Flow-404.16K-404.16K92.89K-404.16K66.99K66.99K-81.59K-79.30K-51.76K-92.04K-5.32K
Financing Cash Flow100174.90K65.76K1.98M430.25K371.87K7.63M160.07K2.09M8.54M5.40M
Capital Expenditure4.16K4.16K4.16K4.16K81.59K81.59K81.59K79.30K51.76K92.04K5.32K
Free Cash Flow--147.92K-92.86K-1.11M-894.47K-297.06K-2.89M-3.07M-3.58M-4.72M-5.13M
Dividends Paid002.50M0--196.59K296.88K---
FCF to OCF-100.00%100.00%100.38%100.00%100.00%102.90%102.65%101.47%101.99%100.00%
Dividend Paid to FCF-0.00%-2692.28%0.00%---6.80%-9.68%---

Earnings

Report DateJan 31, 2018May 1, 2018Oct 3, 2018Dec 14, 2018Apr 20, 2019Jun 13, 2019Sep 13, 2019Dec 12, 2019Apr 14, 2020Jun 4, 2020Sep 11, 2020Dec 15, 2020Apr 2, 2021Jun 14, 2021Sep 3, 2021Dec 14, 2021Apr 29, 2022May 31, 2022Sep 8, 2022Dec 2, 2022Apr 26, 2023Jun 9, 2023Sep 11, 2023Dec 13, 2023Apr 30, 2024May 1, 2024Sep 3, 2024Dec 10, 2024Apr 28, 2025May 30, 2025Sep 9, 2025Dec 11, 2025Apr 29, 2026May 1, 2026Sep 4, 2026
EPS Estimate----0.04-0.07-0.06-0.08-0.08-0.11-0.06-0.030.00-0.050.01-0.03-0.09-0.06-0.07-0.07-0.05-0.06-0.07-0.06-----0.12-0.16-0.17-2.13-1.89-1.89-
EPS Actual-0.40-0.10-0.36-0.07-0.08-0.10-0.07-0.05-0.11-0.28-0.03-0.01-0.33-0.05-0.07-0.23-0.46-0.08-0.12-0.14-0.17-0.13-0.11-0.22-0.23-0.21-0.15-0.12-0.51-0.12-2.12-0.32-0.04-0.08-0.07
Surprise-----300.00%-42.86%-16.67%37.50%-37.50%-154.55%50.00%66.67%-0.00%-800.00%-666.67%-411.11%-33.33%-71.43%-100.00%-240.00%-116.00%-51.29%-274.50%-----325.00%25.00%-1147.06%84.98%97.88%95.79%-
Timing---After-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours--

Key Statistics & Ratios

Market Cap100.04M
Enterprise Value86.15M
Trailing P/E0.00
Forward P/E370.37
Price / Sales61.84
Price / Book16.78
EPS-0.60
Book Value0.438
Revenue (TTM)1.62M
Gross Profit (TTM)536.12K
EBITDA-6.90M
Profit Margin0.00%
Operating Margin-203.57%
Return on Equity-100.75%
Return on Assets-53.48%
Shares Outstanding12.16M
Shares Float5.28M
Beta2.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 15.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
2.90%
Insiders
59.09%
Retail / Other
38.01%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    174.93K1.44%
  • Geode Capital Management, LLC
    70.05K0.58%
  • UBS Group AG
    32.66K0.27%
  • Vanguard Fiduciary Trust Co
    25.11K0.21%
  • State Street Corp
    24.97K0.21%
  • Citadel Advisors Llc
    19.00K0.16%
  • Northern Trust Corp
    13.95K0.11%
  • Haven Private, LLC
    11.37K0.09%
  • BlackRock Inc
    9.54K0.08%
  • Advisor Group Holdings, Inc.
    4.85K0.04%
  • Vanguard Global Advisers, LLC
    2.70K0.02%
  • Wells Fargo & Co
    2.60K0.02%
  • Tower Research Capital LLC
    1.03K0.01%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    122.59K1.01%
  • Fidelity Extended Market Index
    26.22K0.22%
  • iShares Micro-Cap ETF
    9.93K0.08%
  • Fidelity Total Market Index
    9.77K0.08%
  • Fidelity Nasdaq Composite Index
    8.24K0.07%
  • Fidelity Series Total Market Index
    7.23K0.06%
  • Vanguard U.S. Eq Idx £ Acc
    2.70K0.02%

Stock Splits

  • Aug 12, 20221166:1000